PRESS RELEASE published on 01/31/2024 at 09:12, 9 months 21 days ago Preliminary figures for 2023 KSB SE & Co. KGaA closes 2023 financial year with positive results, including increased order intake and sales revenue, driven by strong performance in project business and KSB SupremeServ Segment. Earnings before finance income/expense and income tax (EBIT) substantially above prior-year period 2023 Financial Year EBIT Order Intake Sales Revenue KSB SE & Co. KGaA
PRESS RELEASE published on 11/09/2023 at 09:04, 1 year ago KSB SE & Co. KGaA: KSB very satisfied with performance in the first three quarters
PRESS RELEASE published on 08/03/2023 at 09:15, 1 year 3 months ago KSB continues its positive development in the first half of the year
PRESS RELEASE published on 07/17/2023 at 13:18, 1 year 4 months ago EQS-Adhoc: KSB SE & Co. KGaA updates outlook for 2023
PRESS RELEASE published on 05/04/2023 at 15:41, 1 year 6 months ago Annual General Meeting of KSB SE & Co. KGaA
PRESS RELEASE published on 04/27/2023 at 09:03, 1 year 6 months ago KSB SE & Co. KGaA: Press release Q1 / 2023
PRESS RELEASE published on 03/23/2023 at 12:22, 1 year 7 months ago KSB SE & Co. KGaA: KSB continues its successful course in the 2022 financial year
Published on 11/21/2024 at 14:00, 16 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 16 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 16 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 46 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 41 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 1 minute ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 56 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 31 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 31 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo